ESM1 antibody

Catalog No. ABIN1589869

Product Details anti-ESM1 Antibody

Target: ESM1 (Endothelial Cell-Specific Molecule 1 (ESM1))

Reactivity: Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This ESM1 antibody is un-conjugated

Application: Western Blotting (WB)

Purpose: Endocan/ESM-1 antibody

Specificity: Recombinant mouse ESM-1

Characteristics: Chromosomal location: 13 D2.2, 13

Purification: Protein A purified

Immunogen: Recombinant mouse ESM-1 (ABIN1589771)

Isotype: IgG

Application Details

Application Notes: Western Blot: use at 1-5 μg/mL.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

Buffer: PBS

Handling Advice: Centrifuge vial prior to opening.

Storage: 4 °C,-20 °C

Storage Comment: The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.

Expiry Date: 24 months

Target Details for ESM1

Target: ESM1 (Endothelial Cell-Specific Molecule 1 (ESM1))

Alternative Name: Endocan/ESM-1 (ESM1 Products)

Synonyms: ESM1 antibody, zgc:153027 antibody, 0610042H23Rik antibody, AV004503 antibody, ESM-1 antibody, Pg25 antibody, endocan antibody, endothelial cell specific molecule 1 antibody, endothelial cell-specific molecule 1 antibody, ESM1 antibody, esm1 antibody, Esm1 antibody

Background: Esm1, ESM-1, AV004503, 0610042H23Rik,Endocan (endothelial cell proteoglycan), also known as endothelialcell specific molecule1 (ESM-1), is a 50 kDa monomeric, secreted, cysteinerich proteoglycan identified initially in endothelial cells of the kidney and lung. Mouse Endocan is synthesized as a 184 amino acid (aa) precursor that contains a 21 aa signal sequence and a 20 kDa, 163 aa mature region. The N-terminal 2/3 of the molecule contains 18 cysteine residues and there are no potential N-linked glycosylation sites. Based on human Endocan, there are at least two potential O-linked glycosylation sites, one of which will likely be utilized on Ser at position # 136 of the mature molecule. The posttranslational modification is approximately 30 kDa in size. It consists of a single dermatan sulfate chain that contains 4O sulfated N-acetyl galactosamine with αiduronate. This chain is suggested to bind HGF and contribute to HGF mitogenic activity. Mature mouse Endocan shares 96 % and 74 % aa identity with rat and human Endocan, respectively. In human, there is a potential for an alternate splice variant. It shows a deletion of aa 82-131, a range which would not remove the dermatan sulfate attachment site. It is not known if such a splice form exists in mouse. Endocan is expressed by endothelial cells, adipocytes, bronchial epithelium and distal renal tubular epithelium. It is upregulated by TNFα and VEGF, and is known to bind to LFA1 (integrin αLβ2) on the surface of PBMCs, blocking LFA1 interaction with ICAM1. Normal circulating levels of Endocan are approximately 1 ng/mL.

Gene ID: 71690

NCBI Accession: NM_023612, NP_076101

UniProt: Q9QYY7

Pathways: Growth Factor Binding